Health Catalyst (HCAT) Misses Q4 EPS by 54c, provides guidance

Health Catalyst (NASDAQ: HCAT) reported Q4 EPS of ($0.53), $0.54 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $75.08 million versus the consensus estimate of $73.57 million.

GUIDANCE:

Health Catalyst sees FY2024 revenue of $304-312 million, versus the consensus of $324.4 million. Adjusted EBITDA between $24 million and $26 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02
• Stantec (STN) Tops Q2 EPS by 47c